Search Results for 'Metastatic Nsclc'

Endocrine resistant hormone positive metastatic breast canc

• yoshiko-marsland
• 16 Slides

HOPC. Mrs GV is a 78 year old women who presented...

WHEN CAER ELLREK OFF THE PRIMARY TUMOR and travel through the bloodstr

• celsa-spraggs
• 100 Slides

atienGuideto Metastatic CancerND PROcancers are de...

Empowering you to make informed decisions and to cope with your emotio

• luanne-stotts
• 100 Slides

METASTATIC presented by: ell us what you think of...

Cell migration is an essential

• alida-meadow
• 100 Slides

Background component of metastatic dissemination ...

Metastatic spinal cord compression

• test
• 100 Slides

Diagnosis and management of adults at risk of and ...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

• test
• 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

Melanoma

• olivia-moreira
• 34 Slides

Sandy Beam RN, OCN, CCRC. Research Nurse Clinicia...

The Utility of Surgical Excision in the Contemporary Treatm

• alexa-scheidler
• 12 Slides

Summary. Retrospective, single institutional stud...

Circulating Tumor Cells

• yoshiko-marsland
• 10 Slides

Circulating Tumor Cells (CTC). Metastasis. : the ...

An Analysis on Cytology Diagnoses of the Effusion

• conchita-marotz
• 52 Slides

using LBC Technology. Jong Yull Kim, Prof.,PMIAC...

Audit of patients diagnosed with colorectal cancer within t

• giovanna-bartolotta
• 17 Slides

Clare Westwood. Colorectal Nurse Consultant. Coun...

50 Years

• test
• 17 Slides

بثينه. عناد. ديالى. Classic histor...

Acquisition of tumour multidrug resistance inevitable in mo

• conchita-marotz
• 27 Slides

Failing to cure the majority of advanced solid . ...

Ovarian Tumors

• lindy-dunigan
• 34 Slides

- Ovarian cancer accounts for 3% of all cancers ...

Metastatic Breast Cancer

• lindy-dunigan
• 36 Slides

A sub-focus on specific clinical scenarios. What ...

Management of metastatic and recurrent head and neck cancer

• liane-varnes
• 42 Slides

Erin Alesi, MD. Medical Oncology. , Palliative Me...

Thomas E. Keane

• danika-pritchard
• 35 Slides

Medical University of South Carolina . Charleston...

Pituitary Carcinoma Presenting with Extensive Orbital Infla

• lindy-dunigan
• 6 Slides

Tasneem Kaleem MD. 1. , Jennifer Peterson MD. 1. ...

Metastatic Renal Cell Carcinoma

• myesha-ticknor
• 0 Slides

Program Goals. Incidence of RCC in the United Sta...

Radiology Pathology Correlation

• luanne-stotts
• 0 Slides

Patient Presentation. Casey Morrison, MS4 Sep...

Case Discussion A 52-year-old man initially presented with

• lois-ondreau
• 0 Slides

nonmuscle. -invasive . bladder cancer. He receive...

Finding the Right Fit: Personalizing Treatment in Metastatic Castration-Resistant Prostate Cancer

• pamella-moone
• 0 Slides

This program will include a discussion of . off-l...

Sipuleucel -T Survival Benefit

• calandra-battersby
• 0 Slides

Sipuleucel. -T was approved based on HR of 0.775 ...

Matthew D. Galsky, MD Director, GU Medical Oncology

• luanne-stotts
• 0 Slides

Tisch. Cancer Institute. Icahn School of Medicin...

SARC020 – EORTC 62091 TRUSTS – A phase IIb/III multicenter study comparing the efficacy of TRab

• tatiana-dople
• 0 Slides

Study PI: James Butrynski, MD. Dana . Farber. Ca...

Dose finding designs driven by immunotherapy outcomes with Application to a metastatic melanoma pha

• lois-ondreau
• 0 Slides

Elizabeth Garrett-Mayer, PhD. Cody Chiuzan, MS. H...

Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer

• min-jolicoeur
• 0 Slides

This program will include a discussion of off-lab...

ADVANCES IN THERAPY FOR SARCOMA AND GIST

• ellena-manuel
• 0 Slides

Angela . Cioffi. , MD. Sarcoma Research Program c...

NY-ESO-1 Specific T Cell Therapy for Patients with Metastatic Sarcoma

• giovanna-bartolotta
• 0 Slides

Seth M. Pollack, . MD. Associate in Clinical Rese...

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

• alexa-scheidler
• 15 Slides

Phase I Study of Olaparib and Temozolomide, in pa...

ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES

• min-jolicoeur
• 58 Slides

ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTA...

Targeting endocrine-resistance pathways in breast cancer

• alexa-scheidler
• 48 Slides

Targeting endocrine-resistance pathways in breas...

What’s Positive about Triple Negative Breast Cancer

• myesha-ticknor
• 55 Slides

What’s Positive about Triple Negative Breast Ca...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

• marina-yarberry
• 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

• karlyn-bohler
• 15 Slides

Phase I Study of Olaparib and Temozolomide, in pa...

Hormone Receptor Positive Metastatic Breast Cancer

• pamella-moone
• 80 Slides

. 5/9/2017. The Lancet July 11, 1895. ON THE TRE...

Proteomics of Tissue Tropism in Breast

• heartfang
• 26 Slides

Cancer (mostly). Lauren Barney. Peyton Lab. March ...

Eribulin Mesylate + Trastuzumab

• easyho
• 10 Slides

as First-Line Therapy for Locally Recurrent or . M...

CASE 1: Management of metastatic disease in a resource-limited setting

• sialoquentburberry
• 15 Slides

Dr Sitna Mwanzi. Medical Oncologist. Aga Khan Univ...

• thousandnike
• 39 Slides

actual. . video-recorded proceedings from the . l...